Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) Trial
The PRESERVE (Predicting the Safety and Effectiveness of Inferior Vena Cava Filters) Trial, is the first large-scale, multi-specialty, prospective clinical study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United States. With the guidance of the Food and Drug Administration (FDA), the study will help determine how well filters prevent pulmonary embolisms and when retrievable filters should be removed, thus advancing patienty safety.
The trial is sponsored by the IVC Filter Study Group Foundation, a joint collaboration between the Society of Interventional Radiology and the Society for Vascular Surgery.
Currently, the study is recruiting patients. For additional information about participating sites, please visit ClinicalTrials.gov.